Inbrain Has Sights On Parkinson’s Following First-In-Human Test Of Graphene-Based Implant

Spain-based Inbrain Neuroelectronics plans first-in-human study to show safety of its graphene-based technology in direct contact with human brain while also developing a second interface for treating Parkinson’s disease.